JYB — Jyong Biotech Balance Sheet
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual balance sheet for Jyong Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 0.812 | 0.177 |
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 2.46 | 1.84 |
| Net Property, Plant And Equipment | 6 | 3.54 |
| Other Long Term Assets | ||
| Total Assets | 8.74 | 8.25 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 12.9 | 14.3 |
| Long Term Debt | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 38.4 | 42.3 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Treasury Stock | ||
| Other Equity | ||
| Total Equity | -29.6 | -34.1 |
| Total Liabilities & Shareholders' Equity | 8.74 | 8.25 |
| Total Common Shares Outstanding |